Skip to main content
Publications
Xu X, Kwiatek J, Chehade M, Aceves S, Maslova E, Kielar D, Stirnadel-Farrant H, Meyers J, Candrilli S, Katial R. Characteristics of and healthcare cost drivers among U.S. patients with eosinophilic esophagitis with high versus non-high all-cause costs: an analysis of insurance claims data. Poster presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting; October 24, 2022. Charlotte, NC.
Blonde L, Raccah D, Lew E, Meyers J, Nikonova E, Ajmera M, Davis KL, Bertolini M, Guerci B. Treatment intensification in type 2 diabetes: a real world study of 2-OAD regimens, GLP-1 RAx, or basal insulin. Diabetes Ther. 2018 Jun;9(3):1169-84. doi: 10.1007/s13300-018-0429-x
Nagar SP, Rane PP, Fox KM, Meyers J, Davis K, Beaubrun A, Inomata H, Qian Y, Kajinami K. Treatment patterns, statin intolerance, and subsequent cardiovascular events among Japanese patients with high cardiovascular risk initiating statin therapy. Circ J. 2018 Mar 23;82(4):1008-16. doi: 10.1253/circj.CJ-17-0811
Blonde L, Lew E, Raccah D, Meyers J, Ajmera M, Davis K, Bertolini M, Guerci B. A real-world comparison of outcomes in patients receiving three oral antidiabetic therapies, GLP-1, or basal insulin: an analysis of electronic medical record data. Poster presented at the American Diabetes Association 77th Scientific Sessions; June 10, 2017. San Diego, CA.
Nagar SP, Fox KM, Rane PP, Beaubrun A, Qian Y, Inomata H, Davis KL, Meyers J, Kajinami K. Incidence of cardiovascular events among secondary prevention patients treated with statins or ezetimibe in Japan. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 23, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A261.
Kajinami K, Nagar SP, Meyers J, Rane PP, Davis K, Fox KM, Beaubrun A, Inomata H, Qian Y. Treatment utilization patterns and possible statin intolerance among high-risk patients in a real-world Japanese population. Poster presented at the 81st Annual Scientific Meeting of the Japanese Circulation Society; March 19, 2017. Kanazawa, Japan.
Blonde L, Kitio-Dschassi B, Guerci B, Meyers J, Berria R, Ajmera M, Nikonova E, Davis K, Bertolini M, Raccah D. A real-world comparison of longitudinal HbA1c and health care costs in patients receiving two oral antidiabetic therapies, GLP-1RAs, or basal insulin. Presented at the 76th American Diabetes Association (ADA) Scientifc Sessions; June 13, 2016. New Orleans, LA.
Blonde L, Kitio-Dschassi B, Guerci B, Meyers J, Berria R, Ajmera M, Nikonova E, Davis K, Bertolini M, Raccah D. A real-world comparison of outcomes in patients receiving two oral antidiabetic therapies, GLP-1RAs, or basal insulin: an analysis of electronic medical record data. Poster presented at the 76th American Diabetes Association (ADA) Scientifc Sessions; June 12, 2016. New Orleans, LA.